Literature DB >> 1978465

The prolonged benzodiazepine withdrawal syndrome: anxiety or hysteria?

A Higgitt1, P Fonagy, B Toone, P Shine.   

Abstract

In an attempt to establish whether prolonged withdrawal symptoms after stopping intake of benzodiazepines is caused by return of anxiety, hysteria, abnormal illness behaviour or the dependence process itself producing perhaps a prolonged neurotransmitter imbalance, a group of such patients suffering prolonged withdrawal symptoms (PWS) was compared on a range of psychophysiological measures with matched groups of anxious and conversion hysteria patients and normal controls. It was found that the psychophysiological markers of anxiety were not marked in the PWS group; nor were the averaged evoked response abnormalities found to be associated with cases of hysterical conversion in evidence. The PWS group were hard to distinguish from normal controls on the basis of psychophysiological measures and thus it was felt to be unlikely to be an affective disturbance. It was concluded that PWS is likely to be a genuine iatrogenic condition, a complication of long-term benzodiazepine treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978465     DOI: 10.1111/j.1600-0447.1990.tb01375.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

1.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

Review 2.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Authors:  Malcolm Lader; Andri Kyriacou
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

Review 3.  Benzodiazepine dependence and its treatment with low dose flumazenil.

Authors:  Sean David Hood; Amanda Norman; Dana Adelle Hince; Jan Krzysztof Melichar; Gary Kenneth Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 4.  Prescription Sedative Misuse and Abuse.

Authors:  Michael F Weaver
Journal:  Yale J Biol Med       Date:  2015-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.